Skip to main content
. Author manuscript; available in PMC: 2015 Mar 23.
Published in final edited form as: Gynecol Oncol. 2012 Mar 22;125(3):635–639. doi: 10.1016/j.ygyno.2012.03.023

Table 2.

Adverse Events (N=31)

Grade

Adverse Events 0 1 2 3 4 5
Leukopenia 27 2 2 0 0 0
Thrombocytopenia 28 3 0 0 0 0
Neutropenia 27 3 1 0 0 0
Anemia 21 5 5 0 0 0
Other Hematologic 30 0 1 0 0 0
Constitutional 18 10 1 2 0 0
Dermatologic 23 8 0 0 0 0
Gastrointestinal 23 3 4 1 0 0
Hemorrhage 29 1 0 0 0 1
Lymphatics 30 1 0 0 0 0
Metabolic 28 2 1 0 0 0
Neurosensory 30 1 0 0 0 0
Other Neurological 30 1 0 0 0 0
Pain 21 9 1 0 0 0
Pulmonary 30 1 0 0 0 0